Antibody production
-
Antibody productionThe benefits and limitations of using hybridoma technology to discover new antibodies
Philippe Funfrock
The hybridoma technology, first developed in 1975 by Köhler and Milstein is considered one of the greatest breakthroughs in the field of biotechnology. For the past decades, hybridomas have fueled…
-
In vivo vs. in vitro techniques for custom antibody generation
The first stage of custom antibody generation consists of the creation and maturation of these molecules in vivo (immunization) or… Read More
-
Tips to choose the best monoclonal antibody production process for your project
Early monoclonal antibody production processes relied on the use of immortalized hybridoma cell lines. However, these early production methods faced… Read More
-
Antibody synthesis: How it works and how to leverage it to develop new drugs
The development of any successful antibody therapy starts by first understanding the process of antibody synthesis and its role in… Read More
-
How to choose the right antibody production process for your project
The value of the antibody-antigen interaction, recognized by the end of the 19th century, has given rise to the development… Read More
-
Why you should consider developing a humanized antibody for therapeutic applications
Early antibody therapy relied on antibodies developed from mouse cell lines. However, due to the low complementarity of these molecules… Read More
-
How to choose the best host species for your polyclonal antibody production?
When considering polyclonal antibody production, the host selection is an important decision to take. This choice will condition the volume,… Read More
